Search
x mi
mi
Set radius for geolocation

Rare-Disease Treatment From Alnylam Will Cost $450,000 a Year

Rare-Disease Treatment From Alnylam Will Cost $450,000 a Year

Rare-Disease Treatment From Alnylam Will Cost $450,000 a YearAlnylam Pharmaceuticals Inc. won approval from the U.S. Food and Drug Administration for its first-of-a-kind treatment for a rare, often deadly nerve disease and plans to charge about $450,000 a year for the therapy. After expected discounts in the U.S., Alnylam said in a statement that it expects the net cost for the drug to be about $345,000 a year. Alnylam set the price based on what it said was a fair reward for an urgent condition with no other treatments that can stop or reverse the disease.

Leave a Reply

Your email address will not be published. Required fields are marked

Pre-sale Questions